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Brief Definitive Report
The Effect of Immunosuppressive Agents on the
Induction of Nuclear Factors that Bind to Sites on the
Interleukin 2 Promoter
By Angela Granelli-Piperno, Patricia Nolan, Kayo Inaba,
and Ralph M . Steinman
From the Laboratory of Cellular Physiology and Immunology, and Irvington Institute, The
Rockefeller University, New York, New York 10021

Cyclosporin A (CSA), FK506, and glucocorticosteroids all inhibit the production of lymphokines
by decreasing lymphokine gene expression. Previous experiments have defined six different sites
that may contribute to the transcriptional control of the interleukin 2 (IL2) promoter, and for
each, active nuclear binding factors are induced upon mitogenic stimulation. While dexamethasone
markedly blocks the increase in IL2 mRNA in stimulated human blood T cells, we found that
the drug does not block the appearance of factors that bind to the transcriptional control sites
termed AP-1, AP-3, NF-kB, OCT 1, B site, and NF-AT. In contrast, both CSA and FK506 have
similar effects : the drugs cause modest decreases in AP-3 and NF-kB, and marked decreases in
the activity of AP-1 and NF-AT Therefore, CSA and FK506, while chemically different, seem
to act upon a similar pathway that leads to IL2 gene expression, whereas glucocorticoids do
not affect this pathway.

A

variety of immunosuppressants block T cell prolifera
tion and lymphokine production. A major site of action of these immunosuppressive drugs is at the level of lym
phokine gene expression . This was noted first for cyclosporin
A (CSA) (1-4), which acts primarily at the level of lymphokines rather than other components of T cell activation,
such as the p55 IL2R and cfos (2) . Two other drugs, dexamethasone and FK506, also act primarily at the level of 11,2
gene expression (5-7). It is likely that glucocorticoids have
a different mechanism of action than CSA and FK506, since
steroids affect many cell types, whereas CSA and FK506 are
more T cell restricted .
To gain more insight into the mechanism ofaction of immunosuppressive drugs, we have taken advantage of recent
progress in defining nuclear factors that bind to the IL2 promoter. An activation-dependent enhancer within sequences
-326 to -52 of the 5' flanking region of the IL2 gene has
been identified (for review see reference 8). In this enhancer
reside several elements common to other genes, like the NFkB,
AP-1, AP-3, and OCT-1 sites, as well as a site that seems restricted to activated lymphoid cells and is called the nuclear
factor for activated T cells (NF-AT) (9) . Here, we report the
induction of these nuclear factors in primary populations of
human blood T cells . We show that FK-506 and CSA
markedly inhibit the activation of factors that bind to the
AP-1 and NF-AT sites, whereas dexamethasone has no effect
on all six nuclear binding factors tested .
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Materials and Methods
Cell Cultures. Briefly, human mononuclear cells were isolated from
huffy coats on Ficoll-Hypaque density gradients, washed in PBS,
and rosetted with neuraminidase-treated sheep erythrocytes. The
rosette-positive fraction was further purified by passage over a nylon
wool column and used as a source of T cells. T cells were cultured
at 5 x 106/ml in RPMI 1640 supplemented with 10% heatinactivated FCS, 20,ug/ml gentamicin sulfate, and 5 x 10-5 M
2-ME. Cells were stimulated with PHA (Gibco Laboratories, Grand
Island, NY) at 1 Rg/ml and PMA (Sigma Chemical Co., St. Louis,
MO) at 5 ng/ml in the presence or absence of CSA or CSH (Sandoz,
Basel, Switzerland) at 1 hg/ml; FK506 (Fujisawa Pharmaceutical
Co. Ltd., Osaka, Japan) at 100 ng/ml ; or dexamethasone (Sigma
Chemical Co.) at 10-7 M.
Nuclear Extracts. These were prepared from 2-4 x 108 T cells
by homogenization in two-cell pellet volumes of 10 mM Hepes,
pH 7.9, 10 mM KCI, 1.5 mM MgCIZ, 1 mM EDTA, 0.5 mM
DTT, 0.5 mM PMSF, and 10% glycerol (10). Nuclei were centrifuged at 1,000 g for 5 min, washed, and resuspended in two
volumes of the above solution . 3 M KCI was added drop by drop
to reach 0.39 M KCI . Nuclei were extracted at 4°C for 1 h and
centrifuged at 100,000 g for 30 min . The supernatants were dialyzed in 20 mM Hepes, pH 7 .9, 50 mM KCI, 20% glycerol, 0.5
mM PMSF, and 1 mM EDTA, and"then clarified by centrifugation
and stored at -80°C. Protein concentration was determined using
the Bradford method .
DNA-Protein Binding Assay. 0.2 ng (-10' cpm) of end-labeled
DNA fragments were incubated at room temperature for 20 min
with 5-10 jug of nuclear protein in the presence of 2 pg Poly(dl-
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dC) in 20 jl of 10 mM Tris HCI, pH 7.5, 50 mM NaCl, 1 mM
EDTA, 1 mM DTT, and 5% glycerol (this buffer was used for NFkB, NF-AT, and B sites) . For AP-1, AP-3, and OCT-1 sites, the
buffer was 20 mM Hepes, pH 7.9, 4% Ficoll, 2.5 MM MgCIZ,
1 mM DTT, and 40 mM KC1. Protein-DNA complexes were separated from free probe on a 4% polyacrylamide gel in 0.25x TBE
at 150 V for 1.5 h at room temperature . The gels were dried and
exposed to X-ray film . For each site, we verified that a 20-fold molar
excess of specific cold oligonucleotide would compete the binding
of proteins to a radiolabeled probe, whereas a similar excess from
another site would not.

DNA Probes . Oligonucleotides were synthesized by The Rockefeller University Facility with a DNA synthesizer (Applied Biosystems, Inc., Foster City, CA). The following probes were used :
the NF-AT binding site, -254 to -285 of the IL-2 promoter,
5'-GGAGGAAAAACTGTTTCATACAGAAGGCGT3' (9); the
NF-kB binding site, -206 to -195 region of the 11,2 promoter,
5'-GGGATTTCACCT3' (11); the OCT-1 binding site, 5'-ACT
CTTCACCTTATTTGCATAAGCGATTCTA 3', used for the purification of the OTF-1 transcription factor and kindly provided by
Dr. N . Heintz (The Rockefeller University) ; the AP-1 binding site,
-157 to -140 of the IL2 promoter, 5'-TTCCAAAGAGTCAT

Figure 2. Effects of FK506 on the
induction of nuclear factors that
bind to elements of the 11,2 enhancer. The experiments were the
same as those in Fig. 1, except that
FK506 (100 ng/ml) was used as the
immunosuppressant, and nuclear
extracts from Hela cells were also
tested . Arrows indicate the specific
DNA-protein complexes.
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Figure 1. Effects of CSA on the
induction of nuclear factors that
bind to elements of the 11,2 enhancer. Human blood T cells were
left unstimulated (Unst) or were
stimulated with PHA (1 gg/ml) and
PMA (5 ng/ml) (PIP) in the presence or absence of CSA or the
nonimmunosuppressive analogue
CSH (1 Ftg/ml). After 5 h, the cells
were collected and nuclear extracts
prepared . 10 Rg of nuclear proteins
were incubated with 0.2 ng of the
indicated 32P end-labeled oligonucleotides. Protein-DNA complexes
(arrows) were separated from free oligonucleotide (lower part of each
lane) in low ionic strength 4% polyacrylamide gels .

Effects of CSA on the induction of nuclear factors in response
to mitogenic anti-T cell mAb. The experiments were the same as those
in Fig. 1, except that an anti-CD28 mAb, 9.3 (ascites, kindly provided
by Dr. P. Martin, Seattle, WA, and used at 1:1,000), was used instead
of PHA as the mitogen.
Figure 3 .

CAG3' (11) ; the AP-3 binding site used for the purification of AP-3,
5'-TGTGGAAAGTCCCA-3' (12) ; and the B site, -82 to -67 of
the 11,2 promoter, 5'-TAATATGTAAAACATT3' (13) . Probes were
labeled with [32 p]ATP.

We next examined the effect of another immunosuppressive drug, FK506 . FK506, like CSA, inhibits T cell proliferation and IL2 gene expression (5), which we confirmed.
FK506 proved to be similar to CSA at the level of nuclear
transcription factors. The inductions of NF-AT and AP-1 were
markedly reduced, whereas AP-3, NF-kB, OCT 1, and the
factor that binds to the B site were not (Fig . 2) . We simultaneously evaluated extracts of HeLa cell nuclei . These contained all the nuclear factors that were inducible in T cells,
except for NF-AT, thus confirming that NF-AT is at T cell-restricted activity.
In additional experiments, CSA and FK506 blocked the
induction of nuclear factors in response to the other mitogens,
anti-CD3 (not shown) or anti-CD28 mAb (Fig. 3) . Some
authors find that stimulation with anti-CD28 is CSA resistant (15), but we noted that CSA reduced the induction of
IL2 mRNA as well as nuclear factors that bind the IL-2 promoter (16) (Fig. 3) .
We last tested dexamethasone, a glucocorticosteroid that
also inhibits the increase in IL2 mRNA that occurs during
mitogenesis (6, 7). While the drug clearly blocks the induction of IL-2 mRNA (not shown), dexamethasone did not
alter the induction of any of the factors that bind to the elements we have examined (Fig. 4) . These data indicate that
the 1172 transcriptional control pathway that is suppressed
by glucocorticoids is different from that of CsA and FK506 .

Results and Discussion
DNA-nuclear protein interactions were monitored with
standard electrophoretic mobility shift assays (EMSA) . Extracts of nuclei from mitogen stimulated T cells were prepared 5 h after application of the mitogen in the presence
or absence of an immunosuppressive drug. Resting T cells
did not contain active factors that bind to the NF-AT, NFkB, AP-1, AP-3, and B sites, but these activities were induced
by stimulation with PHA and PMA (Fig. 1) . The immunosuppressive CSA, but not the nonimmunosuppressive analogue
CSH, markedly inhibited the induction of NF-AT and AP-1,
but only partially blocked induction of NF-kB and AP-3 (Fig.
1) . Inhibition by CSA of NF-AT was also observed in stimulated Jurkat cells (14). The fact that CSA primarily acts on
NF-AT and AP-1 is of interest . Both are distinct from other
transcription factors in requiring new protein synthesis as well
as two signals, in this case lectin plus PMA (Granelli-Piperno,
A., manuscript submitted for publication) .
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Effects ofdexamethasone on the induction of nuclear factors
that bind to elements of the IL2 enhancer. The experiments were the same
as those in Fig . 1, except that dexamethasone (10 -7 M) was used as the
immunosuppressive . Arrows indicate the specific DNA-protein complexes .
Figure 4.
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